María Josefa Martínez Ramírez-rekin lankidetzan egindako argitalpenak (2)

2019

  1. Lactobacillus reuteri v3401 reduces inflammatory biomarkers and modifies the gastrointestinal microbiome in adults with metabolic syndrome: The PROSIR study

    Nutrients, Vol. 11, Núm. 8

2018

  1. Evaluation of the effect of Lactobacillus reuteri V3401 on biomarkers of inflammation, cardiovascular risk and liver steatosis in obese adults with metabolic syndrome: A randomized clinical trial (PROSIR)

    BMC Complementary and Alternative Medicine, Vol. 18, Núm. 1